Skip to main content
NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.32%AUDUSD-1.14%GBPCHF+1.00%GBPCAD+0.83%USDCHF+0.80%AUDJPY-0.78%EURGBP-0.67%EURAUD+0.66%USDCAD+0.65%GBPNZD+0.65%AUDNZD-0.65%USDTHB+0.60%GBPJPY+0.56%AUDCAD-0.51%EURUSD-0.50%NZDUSD-0.49%GBPTRY+0.41%CHFJPY-0.38%USDJPY+0.38%AUDCHF-0.37%PLNJPY+0.34%GBPHKD+0.32%NZDCHF+0.31%EURCHF+0.30%NOKJPY+0.29%GBPMXN-0.28%USDTRY+0.28%CADJPY-0.26%SGDJPY+0.26%GBPZAR+0.18%GBPUSD+0.18%EURZAR+0.17%NZDCAD+0.16%USDILS+0.16%USDCNH-0.16%EURCAD+0.15%CADCHF+0.15%USDZAR+0.14%EURJPY-0.12%NZDMXN+0.12%CHFSGD+0.11%NZDJPY-0.09%USDMXN+0.09%CHFNOK+0.09%EURSGD+0.07%EURCNH+0.07%NZDSGD+0.07%GBPSGD+0.07%AUDDKK-0.06%EURNOK+0.06%USDDKK-0.05%CHFSEK+0.04%USDSEK-0.04%USDPLN-0.04%USDCOP-0.04%USDHKD+0.04%EURCZK-0.03%USDSGD+0.03%EURHKD+0.03%AUDSGD+0.02%EURNZD+0.01%USDNOK+0.01%EURSEK+0.01%AUDNOK0.00%EURDKK0.00%EURPLN0.00%XPTUSD-0.91%HG1-0.56%GAGUSD-0.46%XAGUSD-0.46%W1+0.39%GAUUSD-0.33%XAUUSD-0.33%UKOIL+0.28%C1+0.23%XNGUSD+0.13%USOIL+0.12%S1-0.10%BTCUSD-0.17%ETHUSD+7.44%USDTUSD-0.02%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+1.04%ZECUSDT+0.46%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.68%XLMUSD+2.39%BCHUSDT-0.29%UNIUSD-0.38%LTCUSD+0.07%HBARUSDT+1.48%SUIUSD+1.88%TONUSD+15.77%TAOUSDT+0.03%AAVEUSD-3.57%DOTUSDT+2.95%ICPUSDT-3.29%ONDOUSDT+0.37%WLDUSDT+10.51%ARBUSDT-0.49%JUPUSDT-0.50%ATOMUSDT+1.16%INJUSDT-2.54%STXUSDT+19.59%FETUSDT+3.82%SEIUSDT+0.33%PYTHUSDT-2.59%TIAUSDT-0.29%IMXUSDT+0.97%GRTUSDT+0.16%OPUSDT+1.31%WIFUSDT+3.04%IOTAUSDT+3.58%POLUSDT-4.29%AXSUSDT+0.85%FARTCOINUSDT-0.55%EOSUSDT+4.55%DYDXUSDT+3.91%GALAUSDT+5.20%ORDIUSDT+1.22%NOTUSDT+1.55%RONINUSDT+0.06%NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.32%AUDUSD-1.14%GBPCHF+1.00%GBPCAD+0.83%USDCHF+0.80%AUDJPY-0.78%EURGBP-0.67%EURAUD+0.66%USDCAD+0.65%GBPNZD+0.65%AUDNZD-0.65%USDTHB+0.60%GBPJPY+0.56%AUDCAD-0.51%EURUSD-0.50%NZDUSD-0.49%GBPTRY+0.41%CHFJPY-0.38%USDJPY+0.38%AUDCHF-0.37%PLNJPY+0.34%GBPHKD+0.32%NZDCHF+0.31%EURCHF+0.30%NOKJPY+0.29%GBPMXN-0.28%USDTRY+0.28%CADJPY-0.26%SGDJPY+0.26%GBPZAR+0.18%GBPUSD+0.18%EURZAR+0.17%NZDCAD+0.16%USDILS+0.16%USDCNH-0.16%EURCAD+0.15%CADCHF+0.15%USDZAR+0.14%EURJPY-0.12%NZDMXN+0.12%CHFSGD+0.11%NZDJPY-0.09%USDMXN+0.09%CHFNOK+0.09%EURSGD+0.07%EURCNH+0.07%NZDSGD+0.07%GBPSGD+0.07%AUDDKK-0.06%EURNOK+0.06%USDDKK-0.05%CHFSEK+0.04%USDSEK-0.04%USDPLN-0.04%USDCOP-0.04%USDHKD+0.04%EURCZK-0.03%USDSGD+0.03%EURHKD+0.03%AUDSGD+0.02%EURNZD+0.01%USDNOK+0.01%EURSEK+0.01%AUDNOK0.00%EURDKK0.00%EURPLN0.00%XPTUSD-0.91%HG1-0.56%GAGUSD-0.46%XAGUSD-0.46%W1+0.39%GAUUSD-0.33%XAUUSD-0.33%UKOIL+0.28%C1+0.23%XNGUSD+0.13%USOIL+0.12%S1-0.10%BTCUSD-0.17%ETHUSD+7.44%USDTUSD-0.02%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+1.04%ZECUSDT+0.46%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.68%XLMUSD+2.39%BCHUSDT-0.29%UNIUSD-0.38%LTCUSD+0.07%HBARUSDT+1.48%SUIUSD+1.88%TONUSD+15.77%TAOUSDT+0.03%AAVEUSD-3.57%DOTUSDT+2.95%ICPUSDT-3.29%ONDOUSDT+0.37%WLDUSDT+10.51%ARBUSDT-0.49%JUPUSDT-0.50%ATOMUSDT+1.16%INJUSDT-2.54%STXUSDT+19.59%FETUSDT+3.82%SEIUSDT+0.33%PYTHUSDT-2.59%TIAUSDT-0.29%IMXUSDT+0.97%GRTUSDT+0.16%OPUSDT+1.31%WIFUSDT+3.04%IOTAUSDT+3.58%POLUSDT-4.29%AXSUSDT+0.85%FARTCOINUSDT-0.55%EOSUSDT+4.55%DYDXUSDT+3.91%GALAUSDT+5.20%ORDIUSDT+1.22%NOTUSDT+1.55%RONINUSDT+0.06%
BI

Bio-Techne Corporation (TECH)

NASDAQ • Healthcare

$72.47
+$0.09 (+0.1%)
Market closed

Last close at September 30, 2026 at 20:00 UTC

Open$72.38
Day Range$72.33 - $72.55
Avg. Volume (3M)3M
Market Cap$11.3B
P/E Ratio61.9
52 Week Range
$43.2$72.69
Next EarningsIn 34 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$321.1M100%
Gross Profitminus cost of goods$211.3M66%
Operating Incomeminus R&D and overhead$74.2M23%
Net Incomeminus taxes and the rest$54.6M17%

In plain terms: out of every $100 in revenue, Bio-Techne Corporation keeps $17 as net profit.

Fundamentals & Financials

Revenue (TTM)
$1.2B
Net Income (TTM)
$181.8M
EPS (TTM)
$1.17
ROA (TTM)
7.03%
Current Ratio
4.55
Dividend Yield
0.11%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+7.0%Q1 2026$0.46
-3.6%Q2 2026$0.53
+0.2%Q3 2026$0.52
Next

Nov 4

in 34 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +0.2%

Bio-Techne Corporation topped revenue consensus in the fourth fiscal quarter of 2026, with preliminary results reported Aug. 12 showing revenue of $321.2 million against a $314.6 million estimate, +2.1%, and up 1.3% from $317.0 million a year ago. Adjusted EPS came in at $0.52, while net income reached about $54.6 million, versus a loss of $17.7 million a year earlier. Gross profit was roughly $211.4 million, with gross margin near 66%, and operating income was about $74.3 million as operating margin held around 23%. Operating cash flow came to about $95.4 million, the company repurchased about $41.7 million of stock, and it paid about $12.5 million in dividends. For the next period, consensus for EPS is $0.46 on revenue of $292.1 million.

View full earnings history

About Bio-Techne Corporation

Bio-Techne Corporation is a biotechnology company listed on NASDAQ as TECH that develops, manufactures, and sells life science products through subsidiaries. Its portfolio spans research, diagnostic, and bioprocessing markets, with life science reagents, instruments, and services sold across those workflows, and it generated $1.2 billion in FY2025 revenue.

Name
Bio-Techne Corporation
CEO
Kim Kelderman
Website
www.bio-techne.com
Industry
Healthcare
Year Founded
1976
Employees
3,000

Today's Snapshot

AI-generated

TECH closed slightly higher at 72.47, while its sector was weaker. The day ended with TECH within 0.3% of its 52-week high of 72.69.

Trading Volume

Below 10d avg (3.5M)

2.5M

vs S&P 500 Today

Inline with Market

-0.07%

Updated: September 30, 2026 at 20:06 UTC

TECH Headlines

Institutional Moves in Major U.S. Equities

March 12, 2026

4 min read

Institutions Shift Positions Across Key U.S. Stocks

March 1, 2026

4 min read
View All News

Technical Indicators

5 Buy3 Neutral0 Sell
Bio-Techne (TECH) presents a strong bullish technical profile with price trading above the 50-, 100- and 200-day averages and sitting essentially at the classic pivot, which supports the constructive view. ADX shows a firm trend, momentum is mildly positive, and OBV confirms buying interest, while volatility is low as ATR is minimal. Short-term oscillators are neutral to supportive, and the breadth of moving-average support across timeframes indicates a consistent uptrend. Collectively the trend, volume and price structure favor the upside. Technical takeaway: Strong Buy — trend strength, supporting volume and price above key averages align bullishly.
All signals
  • EMA (5 indicators)$64.42 - $72.46
    Buy
  • RSI (14)58.40
    Neutral
  • Stochastic %K (14, 3, 3)60.36
    Neutral
  • MACD Level (12, 26)0.18
    Neutral

Peers & Related Assets

MRNAModerna, Inc.
$192.57-5.3%
RVMDRevolution Medicines, Inc.
$205.26+0.4%
EXELExelixis, Inc.
$58.41-0.4%
JAZZJazz Pharmaceuticals plc
$231.52-0.4%
CORTCorcept Therapeutics Incorporated
$115.23+0.4%
MDGLMadrigal Pharmaceuticals, Inc.
$503.96-1.1%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.